Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06865482 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Course Of Disease In Participants With FA-CM

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Secondary endpoints: 15 to 10
    • Study description shortened, about 30 words
    • Site contacts updated at 3 of 19 sites
    v12
  2. Trial sites expanded: 14 → 19 locationsv11
  3. Trial sites expanded: 10 → 14 locationsv10
  4. Study sites: 9 to 10
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints: 13 to 15
    • Study description expanded, about 30 words
    v9
  5. Study sites: 6 to 9v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 4 to 6v7
  2. Start date changed from estimate of Sep 2025 to Sep 30, 2025v6
  3. Start date: Jul 2025 to Sep 2025
    • Study sites: 3 to 4
    • Primary and study completion dates: Jul 2027 to Sep 2027
    v5
  4. Study sites: 2 to 3v4
  5. Study sites: 1 to 2
    • Primary and study completion dates: Jun 2027 to Jul 2027
    v3
  6. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date: Apr 2025 to Jul 2025
    • Study sites: 0 to 1
    • Primary and study completion dates: Apr 2027 to Jun 2027
    • Secondary endpoints revised (13)
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)
Trial Details
NCT Number NCT06865482
Lead Sponsor Lexeo Therapeutics
Conditions
(from sponsor)		 Friedreich Ataxia, Cardiomyopathy
Related terms Cardiomyopathies, Friedreich Ataxia, Heart Diseases
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov